Subject

In a dystopian New York City, the radioactive dust of nuclear war is everywhere. The trauma of war, the loss of many loved ones, and the pressure to flee has created a lucrative new pharmaceutical industry: memory-erasing drugs. The leading contender in clinical trials is Memredux. Memredux is a powerful medication meant to be taken once a day for one month to erase all memories selected by you and your physician prior to prescription. For the first time, two test subjects for the new drug are relocated to a shared holding pen in Memredux Laboratories. The initial phase of observational research centers on the effect of the drug on the subjects’ first human contact since undergoing treatment. Be the first to attend the observational trial. COVID precautions: Because of its immersive format, Subject is uniquely suited to accommodate pandemic-era health and safety protocol. Guests are required to be fully vaccinated and to wear masks. The venue is 9200 square feet and attendance is limited, so there is plenty of room to maintain social distancing. You will need to show one of the following accepted forms of proof of vaccination, together with a valid photo ID for ages 18+, to a lab attendant when you check in at Memredux Laboratories: - NYC COVID Safe App - New York State Excelsior App or Excelsior Plus App - A photo or hard copy of an official immunization record of a vaccine administered from within or outside the U.S.